Alzamend Neuro (ALZN) stock is on the move Thursday after getting an update from the U.S. Food and Drug Administration (FDA). More
Articles
Aterian Is a Forward-Looking Retail Play Hurt by a Shipping Crisis
ATER stock is worth between $12.38 and $15.38 or 23.5% to 54.4% more, based on higher expected sales by next year. More
The Recent Pullback in AMC Entertainment Stock Is Just the Start
Once its meme bubble bursts, AMC stock will fall toward its underlying value (likely a price in the single-digits). With this in mind, avoid it at all costs. More
5 Things to Know About Grom Social as Investors Squeeze GROM Stock Higher
Grom Social Enterprises (GROM) stock is gaining on Thursday with heavy trading even without there being any news from the company. More
Avalanche Price Predictions: Where Will a Coinbase Listing Take the AVAX Crypto?
Avalanche price predictions are the hot topic among crypto bulls this morning. Coinbase is bringing the AVAX crypto to its platform. More
Coin Burning Strategy Should Get Shiba Inu Out Of the Doghouse
Some cryptos are known for being reliable hedges against inflation, and forward-thinking actions have placed Shiba Inu in this category. More